uniQure N.V. (NASDAQ: QURE) Stock Information | RedChip

uniQure N.V. (NASDAQ: QURE)


$8.96
-0.1550 ( -1.70% ) 654.0K

uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.

Market Data


Open


$8.96

Previous close


$9.11

Volume


654.0K

Market cap


$433.55M

Day range


$8.91 - $9.41

52 week range


$3.73 - $11.35

SEC Fillings


Form Type Description Pages Date
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Mar 05, 2024
4 Insider transactions 1 Feb 28, 2024
8-k 8K-related 16 Feb 28, 2024
4 Insider transactions 1 Feb 28, 2024
4 Insider transactions 1 Feb 28, 2024
10-k Annual reports 125 Feb 28, 2024
5 Other 1 Feb 06, 2024

Latest News